245 Cord blood CD34<sup>+</sup> stem cells are efficiently transduced with anti-CD19-CAR and expanded and differentiated into viveNK™ natural killer cells which display selective cytotoxicity against B-cell leukemiaMonica Raimo, Adil Deniz Duru, Youri van Waardenburg et al.|Regular and Young Investigator Award Abstracts|2022Cited by 0
384 Single-cell transcriptomics, proteomics and in vitro cytotoxicity of allogeneic cryopreserved natural killer cell therapy GTA002 identify potent effector signaturesMonica Raimo, Jan Spanholtz, Adil Deniz Duru et al.|Regular and Young Investigator Award Abstracts|2023Cited by 0
330 Combination therapy with stem cell derived natural killer cells and monoclonal antibodies leads to potent ADCC through engagement of endogenouse CD16Anna‐Maria Georgoudaki, Jan Spanholtz, Nina Lamers-Kok et al.|Regular and Young Investigator Award Abstracts|2023Cited by 0
Umbilical cord blood CD34+ hematopoietic stem cell-derived natural killer cells in Acute Myeloid Leukemia – a phase I clinical studyMichael Heuser, Adil Deniz Duru, Anna‐Maria Georgoudaki et al.|Blood|2025Cited by 0